0000000000285244

AUTHOR

M. Gil-martin

showing 1 related works from this author

LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer

2021

OncologyTIGITbiologyAtezolizumabbusiness.industryCancer researchbiology.proteinMedicineIn patientHematologyAntibodybusinessMetastatic esophageal cancerAnnals of Oncology
researchProduct